Structural and Spectroscopic Characterization of 3-[4-(Trifluoromethyl)Phenyl]-3a,4,8,8a-Tetrahydro-6H-[1,3] Dioxepino[5,6-d][1,2]Oxazole Compound: An Experimental and Density Functional Theory Study

被引:0
作者
H. Gümüş
N. Tekin
Y. S. Kara
机构
[1] Golcuk Vocational School at Kocaeli University,Department of Chemistry, Science and Art Faculty
[2] Kocaeli University,undefined
来源
Journal of Applied Spectroscopy | 2023年 / 89卷
关键词
crystal structure; X-ray diffraction; oxazole; infrared spectrum; nuclear magnetic resonance; density functional theory;
D O I
暂无
中图分类号
学科分类号
摘要
To better understand the molecular definition of 3-[4-(trifluoromethyl)phenyl]-3a,4,8,8a-tetrahydro-6H-[1,3] dioxepino[5,6-d][1,2]oxazole (OXE–OXA) compound, we examined its molecular geometric structure and spectroscopic properties in detail. First, we determined the OXE–OXA compound’s crystal structure using single-crystal X-ray diffraction data, then we grew a single crystal of the OXE–OXA compound using the slow evaporation solution magnification technique at room temperature with ethanol. It was found that the OXE–OXA compound crystallizes in the monoclinic crystal system with the noncentrosymmetric space group P1 21/n1. We performed the theoretical calculations for OXE–OXA compound at the B3LYP/6-311++G(d,p) and HSEh1PBE/6-311++G(d,p) levels of the density functional theory method. According to the comparison of our obtained data, the experimental 1H and 13C nuclear magnetic resonance chemical shifts were in strong agreement with the values for simulated chemical shifts. Later, we investigated the experimental FT-IR and theoretical IR spectrum of OXE–OXA compounds in the 4000–400 cm–1 region.
引用
收藏
页码:1150 / 1157
页数:7
相关论文
共 52 条
[1]  
Prugoveki B(2006)undefined Croatica Chem. Acta C 79 219-226
[2]  
Marinkovi M(2009)undefined Acta Cryst. 65 358-359
[3]  
Vinkovi M(2016)undefined J. Med. Org. Chem. 3 11-20
[4]  
Dumi M(2017)undefined Molecules 22 303-24
[5]  
Gul W(2017)undefined Int. J. Pharm. Pharm. Sci. 9 13-866
[6]  
Carvalho P(1994)undefined Arzneimittelforschung 44 863-3037
[7]  
Galal A(2017)undefined Med. Chem. Res. 26 3026-281
[8]  
Averyb MA(2019)undefined EJPMR 6 274-165
[9]  
El Sohly MA(2019)undefined J. Mol. Struct. 1193 158-341
[10]  
Rani E(2015)undefined Acta Crystallogr. A A71 3-11